Metagenomi, Inc. (MGX)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Ionis	21.92M	Log In	Log In
Ionis Growth	19466.96%	Log In	Log In
Moderna	18.12M	Log In	Log In
Moderna Growth	24.80%	Log In	Log In
Affini-T	4.72M	Log In	Log In
Affini-T Growth	83.74%	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	44.76M	Log In	Log In
United States Growth	160.21%	Log In	Log In